• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTPA2Q1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Dyspnea (1816); Endocarditis (1834); Fall (1848); Unspecified Infection (1930); Pneumonia (2011); Sepsis (2067)
Event Date 05/15/2023
Event Type  Death  
Event Description
It was reported that the patient is deceased.  the patient presented to the emergency department with complaints of dyspnea with worsening heart failure.  the patient was administered diuretic medication.  additionally, it was reported that the patient had a fall two weeks prior with persistent right chest pain.  the patient also suffered from multiple comorbidities heart failure, diabetes and end stage renal disease.  the patient was admitted and diuresed and continued on dialysis.Diagnostic findings were suggestive of pneumonia and echocardiogram revealed left ventricular ejection fraction is increased to seventy-five percent.  urine culture revealed urinary tract infection and multidrug-resistant klebsiella pneumonia.  despite being, treated with antibiotics the patient continued to have fevers, elevated white blood count and bacteremia.  the patient underwent computed tomography arterial portography (ctap), showing acute gallbladder inflammation and c-tube placement with interventional radiology that was complicated by coffee ground emesis.Transesophageal echocardiography (tee) showed lead associated endocarditits.  it was also reported that during hospitalization an exploratory laparotomy with open gall bladder removal, vac placement with second look, with additional bowel resection was performed.  postoperatively, the patient continued to remain on vasopressors with rising lactate, and worsening sepsis shock.Post dis charge, two weeks later the patient passed away.  the patient is a participant in a clinical study.
 
Manufacturer Narrative
Continuation of d10: 505da20 mechanical valve; implanted: on (b)(6) 2010; 694765 lead; implanted: on (b)(6) 2008.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was further reported the tee revealed an echodensity on the right atrial (ra) lead that was noted to likely represent endocarditis given the patient's history of bacteremia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key17438790
MDR Text Key320195800
Report Number9614453-2023-02649
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00763000178109
UDI-Public00763000178109
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/28/2023
Device Model NumberDTPA2Q1
Device Catalogue NumberDTPA2Q1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/01/2023
Supplement Dates Manufacturer Received08/19/2023
Supplement Dates FDA Received09/06/2023
Date Device Manufactured04/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
459878 LEAD, 5076-45 LEAD
Patient Outcome(s) Hospitalization; Death; Required Intervention;
Patient Age64 YR
Patient SexFemale
Patient Weight110 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-